Memorabilia of Beijing Meng Jing Hi-Tech Stem Cell Technology Co., Ltd.

● On June+10, 5438, the Inner Mongolia Stem Cell Medical Engineering and Technology Research Center, which was wholly supported by the company, was approved by the Inner Mongolia government to become a scientific research institution with independent legal personality and competent department of science and technology, marking the comprehensive start of stem cell basic stem cell research, technology development, technology introduction and transformation and clinical application promotion in Meng Jing.

● In February, the seventh cell therapy seminar and CIK technology seminar were successfully held;

● Meng Jing Stem Cell Academician Expert Workstation hired experts such as Mr. Neil Warma (USA), Professor Takasaki (Japan), Professor Tanigawa Keiji (Japan) and Professor Wei Qingyi (Deputy Director of Fudan Cancer Institute) to guide scientific research;

● In March, obtained the certificate of national high-tech enterprise.

● In April, establish strategic cooperation with Alxa League in Inner Mongolia and start major construction projects of bio-industry.

● In May, we established strategic cooperation with the Chifeng Municipal Government of Inner Mongolia, and launched the plan of * * * to build a stem cell industrial park base.

● In June, AG, the chairman of the company, was awarded 20 12 Zhongguancun high-end leading talents.

● In July, the company won the Top 20 of "20 1 1 Zhongguancun High-growth Enterprises Top100".

● In July, the Party branch of Meng Jing Stem Cell Company was formally established.

● In July, the company was approved to formally establish Zhongguancun Open Laboratory (Meng Jing Cell Therapy Research and Related Product Analysis Laboratory).

● 1 1 month, the company officially became the research base of stem cell transformation medicine of Beijing Institute of Life Sciences, China Academy of Sciences.

20 1 1 year:

● In February, the sixth cell therapy seminar was successfully held.

● In September, it became the first batch of scientific and technological enterprises in Zhongguancun Science Park to establish an "academician expert workstation" and invited Academician Lu Shixin to guide scientific research.

● Become a member of the Regenerative Medicine Professional Committee of China Pharmaceutical Biotechnology Association;

● Approved to become a national high-tech enterprise;

● Won the title of Top Ten Industry Leaders in Health China;

● 20 1 1 Member of Regenerative Medicine Committee of China Medical Biotechnology Association.

● 20 1 1 Top Ten Industry Leaders in Healthy China

20 10:

● In March, the fifth cell therapy seminar was successfully held.

● In March, it became the supporting unit of Inner Mongolia Stem Cell Medical Engineering Technology Research Center;

● Approved to become a high-tech enterprise in Zhongguancun;

In 2009:

● The company was established and won the title of off-site stem cell platform of Inner Mongolia Science and Technology Department, and was identified as the undertaker of major innovation guidance fund in Inner Mongolia;

● Become a member of the International Association for Cell Therapy.

Meng Jing Stem Cell "Grassland Seedling Program"

Since 20 10, as an off-site stem cell technology platform established in Beijing by the Inner Mongolia Autonomous Region Stem Cell Medical Engineering Technology Research Center, Beijing Meng Jing Hi-Tech Stem Cell Technology Co., Ltd. has actively launched the "Grassland Seedling Program" to provide a funding and research platform for postgraduate students who are interested in stem cells and related fields in Inner Mongolia.

The specific research fields funded include the basic research and clinical application technology of the culture and characteristics of various stem cells. In addition to the planned funding, the graduate students selected by Class A can also visit and study in Beijing Meng Jing Hi-Tech Stem Cell Company and other related units for one week every year, and all expenses will be paid by the company. Graduate students selected by Class B can be jointly trained by their universities and Meng Jing stem cell companies to carry out research on graduate programs. The specific research content shall be determined through consultation between the company and Selected Graduates. At the same time, the company will provide all living expenses and research expenses for the selected students.

Winners of the above two types of funding have the opportunity to work in relevant institutions of the company after graduation.